BMJ  2007;335:683 (6 October), doi:10.1136/bmj.39353.483160.BE

Letters

Familial hypercholesterolaemia

Cascade testing is tried and tested and cost effective

The first 150 words of the full text of this article appear below.

Wald et al suggest that screening children for high cholesterol at the time of immunisation, and then testing the parents of affected children, is an effective screening method for familial hypercholesterolaemia.1 However, their paper does not address acceptability or cost effectiveness.

Earlier data from our group showed that universal screening was much less cost effective than cascade testing (family tracing from affected patients). A recent pilot study of cascade testing at five NHS trusts, funded by the Department of Health (www.fhcascade.org.uk), has confirmed cascading to be feasible, cost effective, and acceptable to both patients and clinicians.2 Our recommendations to the department include that, because of the degree of overlap in cholesterol concentrations in affected and unaffected individuals, DNA testing is required to underpin a diagnosis of familial hypercholesterolaemia. The use of cholesterol testing as proposed by Wald et al will lead either to many false positive diagnoses in children, causing . . . [Full text of this article]

Gaye S Hadfield, project coordinator, FH cascade testing audit, London IDEAS Genetics Knowledge Park, Steve E Humphries, BHF professor of cardiovascular genetics

Department of Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, London WC1E 6JJ

rmhaseh@ucl.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Screening needs a fresh approach
David S Wald, Jonathan P Bestwick, and Nicholas J Wald
BMJ 2007 335: 1007-1008. [Extract] [Full Text] [PDF]

Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis
David S Wald, Jonathan P Bestwick, and Nicholas J Wald
BMJ 2007 335: 599. [Abstract] [Full Text] [PDF]

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia
Dalya Marks, David Wonderling, Margaret Thorogood, Helen Lambert, Steve E Humphries, and H Andrew W Neil
BMJ 2002 324: 1303. [Abstract] [Full Text] [PDF]

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia
D Bhatnagar, J Morgan, S Siddiq, M I Mackness, J P Miller, and P N Durrington
BMJ 2000 321: 1497. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Chowdhury, T. A, Hitman, G. A (2009). NICE guidance for identification and treatment of familial hypercholesterolaemia: Commentary 1. Heart 95: 587-589 [Full text]  
  • Wald, D. S, Bestwick, J. P, Wald, N. J (2007). Screening needs a fresh approach. BMJ 335: 1007-1008 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ